Medicare drug coverage

Camzyos: 2027 Medicare Part D coverage

363 of 5,495 Part D plans (7%) list Camzyos on their 2027 formulary, the plan's list of covered drugs (down 20 points from 2026). 100% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (5,172 MA-PD) and stand-alone drug plans (323 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

For pharmaciesFor agencies

2027 compared with 2026

Camzyos is number 145 by total Medicare Part D spending in 2024 ($291 million). Plans that list it most often put it on tier 5 (a tier is the cost level a plan puts a drug on; a lower tier usually costs less). Counts use 5 RxNorm products for this name.

Camzyos Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file5,5185,495-23
Plans that list it1,489 (27%)363 (7%)-20 points
Prior authorization (of plans that list it)1,489 (100%)363 (100%)no change
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)1,481 (99%)363 (100%)+1 point
Any of the three (of plans that list it)1,489 (100%)363 (100%)no change
Not listed or restricted (of all plans)5,518 (100%)5,495 (100%)no change

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Every 2027 stand-alone drug plan

Each stand-alone Part D plan (PDP) with Camzyos's 2027 tier and limits. CMS files a PDP once per region, so one plan name can have several plan IDs; the row shows the tier and limits most of them use. Medicare Advantage drug plans are local: pick a state for its plan-by-plan table.

Camzyos on every 2027 stand-alone Part D plan
Plan (PDP)Plan IDs2027 tier2027 limits
AARP Medicare Rx Preferred from UHC (PDP)39Not listedNot listed
AARP Medicare Rx Saver from UHC (PDP)34Not listedNot listed
Blue Medicare Rx Enhanced (PDP)1Not listedNot listed
Blue Medicare Rx Standard (PDP)1Not listedNot listed
Blue MedicareRx Essentials (PDP)1Not listedNot listed
Blue MedicareRx Plus (PDP)1Not listedNot listed
Blue MedicareRx Premier (PDP)1Not listedNot listed
Blue MedicareRx Value (PDP)1Not listedNot listed
Blue MedicareRx Value Plus (PDP)1Not listedNot listed
Blue Shield Rx Enhanced (PDP)1Not listedNot listed
Blue Shield Rx Plus (PDP)1Not listedNot listed
BlueMedicare Complete Rx (PDP)1Not listedNot listed
BlueMedicare Premier Rx (PDP)2Not listedNot listed
BlueMedicare Value Rx (PDP)1Not listedNot listed
BlueRx Enhanced Plus (PDP)1Not listedNot listed
BlueRx Essential (PDP)1Not listedNot listed
HealthSpring Assurance Rx (PDP)35Tier 5PA, QL
HealthSpring Extra Rx (PDP)2Tier 5PA, QL
HealthSpring Extra RX (PDP)3Tier 5PA, QL
Horizon Medicare Blue Rx Enhanced (PDP)1Not listedNot listed
Horizon Medicare Blue Rx Standard (PDP)1Not listedNot listed
Humana Basic Rx Plan (PDP)34Not listedNot listed
Humana Premier Rx Plan (PDP)34Not listedNot listed
Humana Value Rx Plan (PDP)34Not listedNot listed
MedicareBlue Rx Standard (PDP)1Not listedNot listed
Prescription Blue Premium (PDP)1Not listedNot listed
Prescription Blue Select (PDP)1Not listedNot listed
SilverScript Choice (PDP)20Not listedNot listed
Wellcare Classic (PDP)34Not listedNot listed
Wellcare Value Script (PDP)34Not listedNot listed

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Formulary tier

Camzyos formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 145 (3%)8 (2%)
Tier 22 (<1%)1 (<1%)
Tier 415 (1%)12 (3%)
Tier 51,407 (94%)342 (94%)
Tier 620 (1%)0 (0%)

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Plan by plan, 2026 to 2027

4,380 plan IDs are in both files. 0 of them (0%) added prior authorization, step therapy, or a quantity limit for Camzyos, and 899 stopped listing it.

Camzyos: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years4,380
Listed it in 2026, not in 2027899 (21%)
Listed it in 2027, not in 202611 (<1%)
Moved it to a higher tier3 (<1%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit0 (0%)
Added at least one of the three0 (0%)
Removed at least one of the three0 (0%)
Plan IDs new in 20271,115
2026 plan IDs not in the 2027 file1,138

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

States from most to least restrictive

Share of 2027 Part D plans offered in each state that leave Camzyos off the formulary or list it with prior authorization, step therapy, or a quantity limit. All 51 states are at 100%. States at the same share are ordered by the prior authorization or step therapy share; states equal on both shares share a rank, marked Tied.

States from most to least restrictive for Camzyos, 2027
RankState2027 plansNot listed or restrictedPrior auth or step therapyChange from 2026
Tied 1Alabama115100%16%no change
Tied 1Ohio173100%16%no change
Tied 3Georgia151100%13%no change
Tied 3Arkansas86100%13%no change
Tied 3Illinois133100%13%no change
6South Carolina91100%12%no change
Tied 7Mississippi105100%11%no change
Tied 7Alaska9100%11%no change
Tied 9Louisiana126100%10%no change
Tied 9Tennessee157100%10%no change
Tied 9North Carolina177100%10%no change
12Delaware43100%9%no change
Tied 13Michigan183100%8%no change
Tied 13Missouri171100%8%no change
Tied 13Maryland49100%8%no change
Tied 13Texas412100%8%no change
Tied 13Wyoming13100%8%no change
Tied 13Colorado106100%8%no change
Tied 19Vermont14100%7%no change
Tied 19West Virginia70100%7%no change
Tied 19Massachusetts92100%7%no change
Tied 22Oklahoma81100%6%no change
Tied 22Arizona148100%6%no change
Tied 24Kentucky123100%5%no change
Tied 24District of Columbia21100%5%no change
Tied 26New Mexico68100%4%no change
Tied 26New York215100%4%no change
Tied 26New Jersey74100%4%no change
Tied 26New Hampshire25100%4%no change
Tied 26North Dakota26100%4%no change
Tied 26Montana27100%4%no change
Tied 26Pennsylvania324100%4%no change
Tied 26Washington114100%4%no change
Tied 34Rhode Island29100%3%no change
Tied 34South Dakota30100%3%no change
Tied 34Wisconsin97100%3%no change
Tied 34Nevada100100%3%no change
Tied 34Virginia145100%3%no change
Tied 39Idaho45100%2%no change
Tied 39Oregon92100%2%no change
Tied 39Indiana140100%2%no change
Tied 39Florida549100%2%no change
Tied 39Hawaii50100%2%no change
Tied 39Nebraska51100%2%no change
Tied 39Maine52100%2%no change
Tied 39Utah53100%2%no change
Tied 39Connecticut54100%2%no change
Tied 39Minnesota63100%2%no change
Tied 39Iowa64100%2%no change
Tied 39California397100%2%no change
51Kansas84100%1%no change

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

By parent organization

164 parent organizations offer 2027 Part D plans. Humana Inc. has the most, 884, and 100% of them leave Camzyos off or restrict it.

Camzyos coverage by parent organization, 2027
Parent organization2027 plans ↑List itRestrict it (of listing)Not listed or restrictedChange from 2026Plans that added a restriction
BrightSpring Health Services, Inc.20%none list it100%no change0
Community Health Group20%none list it100%no change0
Community Health Plan of Washington2100%100%100%no change0
Denver Health and Hospital Authority20%none list it100%no change0
Elevance Health, Inc. & BCBSMA & BCBSRI & BCBSVT20%none list it100%no change0
Elite Health Systems, Inc.20%none list it100%no change0
Group Health Cooperative of Eau Claire2100%100%100%no change0
Hamaspik of Rockland County, Inc.20%none list it100%no change0
ISNP Holdings, LLC20%none list it100%no change0
Kansas Superior Select20%none list it100%no change0
Missouri Healthcare Advisors, LLC20%none list it100%no change0
MultiCare Health Systems20%none list it100%new in 20270
NEIGHBORHOOD HEALTH PLAN OF RHODE ISLAND20%none list it100%no change0
PrimeWest Rural MN Health Care Access Initiative20%none list it100%no change0
Regency ISNP Holdings LLC20%none list it100%no change0
Select Founders, LLC20%none list it100%no change0
Sentara Health Care (SHC)20%none list it100%no change0
South Country Health Alliance20%none list it100%no change0
The Regents of the University of California20%none list it100%no change0
Troy Holdings, Inc.20%none list it100%no change0
Associated Care Ventures, Inc.30%none list it100%no change0
Aultman Health Foundation30%none list it100%no change0
Banner Health3100%100%100%no change0
Bexar County Hospital District30%none list it100%no change0
Blue Cross Blue Shield of Nebraska30%none list it100%no change0

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Near it by Part D spending

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing